68.0
[]. Ahmad, Z., et al., Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig. J Infect Dis, 00. 00(7): p. 6-4.
[]. Singh, R., et al., PA-84 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science, 008. (506): p. -5.
[]. Suarez, J., et al., An oxyferrous heme/protein-based radical intermediate is catalytically competent in the catalase reaction of Mycobacterium tuberculosis catalase-peroxidase (KatG). J Biol Chem, 00. 84(): p. 707-.
[4]. Timmins, G.S., et al., Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis. Antimicrob Agents Chemother, 004. 48(8): p. 006-.
[5]. A M Upton, et al. In vitro and in vivo activities of the nitroimidazole TBA-54 against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 05 Jan;5():6-44.
H0
P6-P64-P70-P7-P80-P0+P5-P04+P40-P05+P5+P8-P0-P6+P64-P40+P-P405-P50
077